DAWN

Day One Biopharmaceuticals, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website dayonebio.com
Employees(FY) 133
ISIN US23954D1090

Performance

-12.92%

-9.26%

-3.34%

-15.77%

-6.71%

YTD

+12.38%

Profile

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.

Advanced Technical Analysis

Technical Analysis of DAWN 2024-11-20

The stock's Moving Average Score of 10 indicates a strong bearish sentiment, while the Oscillators Score of 50 reflects a neutral stance. Overall, the combined Technical Score of 30 reinforces a bearish outlook, suggesting caution for potential investors.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of DAWN

Stock Rank

Recent News & Updates

2024-11-18 08:30
Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference(GlobeNewswire)
2024-11-17 19:30
Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference(Globenewswire)
2024-11-12 17:04
Day One Biopharmaceuticals Insider Sold Shares Worth $456,223, According to a Recent SEC Filing(MT Newswires)
2024-11-06 09:55
Wall Street Analysts See a 136.83% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High?(Zacks)
2024-11-06 09:02
Exploring Three High Growth Tech Stocks in the United States(Simply Wall St.)
2024-11-04 05:51
Bullish: Analysts Just Made A Huge Upgrade To Their Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Forecasts(Simply Wall St.)
2024-11-01 09:55
We Think Day One Biopharmaceuticals (NASDAQ:DAWN) Can Easily Afford To Drive Business Growth(Simply Wall St.)
2024-10-30 17:20
Day One Biopharmaceuticals, Inc. (DAWN) Surpasses Q3 Earnings and Revenue Estimates(Zacks)
2024-10-30 16:01
Day One Reports Third Quarter 2024 Financial Results and Corporate Progress(GlobeNewswire)
2024-10-30 04:01
Day One Reports Third Quarter 2024 Financial Results and Corporate Progress(Globenewswire)
2024-10-21 09:55
Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 140.71%: Read This Before Placing a Bet(Zacks)
2024-10-16 08:44
Day One Biopharmaceuticals (DAWN): Advancing Targeted Therapies for Pediatric Glioma(Insider Monkey)
2024-10-16 08:30
Day One to Report Third Quarter 2024 Financial Results Wednesday, October 30, 2024(GlobeNewswire)
2024-10-15 20:30
Day One to Report Third Quarter 2024 Financial Results Wednesday, October 30, 2024(Globenewswire)
2024-10-01 20:00
At What Oil Price Will Shale Drillers Stop Drilling?(Oilprice.com)
2024-09-12 16:52
Day One Biopharmaceuticals Insider Sold Shares Worth $426,675, According to a Recent SEC Filing(MT Newswires)
2024-08-28 17:50
Day One Biopharmaceuticals Files Shelf for Share Sale by Stockholders(MT Newswires)
2024-08-27 12:49
Taylor Fritz’s Girlfriend Morgan Riddle Opts for Classic Little Black Dress on Day One of the U.S. Open 2024(WWD)
2024-08-19 11:15
Jeff Bezos Said 'I Predict One Day Amazon Will Fail' And Claims Large Companies Only Last '30-Plus Years' – Guess How Old Amazon Is?(Benzinga)
2024-08-16 07:39
A great week that adds to Day One Biopharmaceuticals, Inc.'s (NASDAQ:DAWN) one-year returns, institutional investors who own 56% must be happy(Simply Wall St.)
2024-08-14 11:46
Bank of America Says Buy These 3 Stocks for a Double-Digit Rally(InvestorPlace)
2024-08-07 07:48
Dow Jones Futures Fuel New Market Rally On Bank Of Japan; Nvidia Partner Super Micro Dives(Investor's Business Daily)
2024-08-06 22:53
Dow Jones Futures Rise On BoJ Signals After Stock Market Rally; Nvidia Partner Super Micro Dives(Investor's Business Daily)
2024-08-06 19:57
Dow Jones Futures: Stock Market Rally Begins; Nvidia Partner Super Micro Falls Late(Investor's Business Daily)
2024-08-01 07:40
BofA Securities Upgrades Day One Biopharmaceuticals to Buy From Underperform(MT Newswires)
2024-07-30 14:29
Day One Biopharmaceuticals Expects to Raise $175 Million in Gross Proceeds From Oversubscribed Private Placement(MT Newswires)
2024-07-30 12:48
Wedbush Trims Day One Biopharmaceuticals Price Target to $32 From $33, Maintains Outperform Rating(MT Newswires)
2024-07-30 09:31
Day One Biopharmaceuticals Q2 Net Loss Narrows(MT Newswires)
2024-07-30 08:40
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q2 Loss, Tops Revenue Estimates(Zacks)
2024-07-30 07:30
Day One Reports Second Quarter 2024 Financial Results and Corporate Progress(GlobeNewswire)

Page 1 of 6

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.